Cormorant Asset Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $20.2M | Hold |
|
|||||
|
2023
Q1 | $21.6M | Sell |
|
|||||
|
2022
Q4 | $32.1M | Sell |
|
|||||
|
2022
Q3 | $26.9M | Buy |
|
|||||
|
2022
Q2 | $10.2M | Sell |
|
|||||
|
2022
Q1 | $18.5M | Buy |
|
|||||
|
2021
Q4 | $5.93M | Sell |
|
|||||
|
2021
Q3 | $5.63M | Sell |
|
|||||
|
2021
Q2 | $6.27M | Sell |
|
|||||
|
2021
Q1 | $7.67M | Buy |
|
|||||
|
2020
Q4 | $1.53M | Buy |
|